Keywords
Abstract
Mazkur ishda qizamiq virusi (morbilli) bilan kasallangan homilador ayollarda kechadigan klinik manzara, bunda ona va rivojlanayotgan homilaga tahdid soladigan asoratlar, shu bilan birga ularning rivojlanishini cheklash bo’yicha hozirgi kunda qo’llanilayotgan tibbiy yondashuvlar ilmiy manbalarni umumlashtirish yo’li bilan yoritilmoqda. Gestatsiya jarayonida kechadigan immun tizimning o’ziga xos o’zgarishlari sababli ushbu yuqori darajada yuqumli infeksiya odatdagidan og’irroq kechib, o’pka yallig’lanishi va statsionar sharoitda davolanish zaruriyatini keltirib chiqarishi, bundan tashqari homila rivojlanishining to’xtab qolishi, muddatidan oldingi tug’ruq holatlari va chaqaloqning yetarli bo’lmagan vazn bilan dunyoga kelish ehtimoli kuchayishi aniqlangan. Tadqiqot davomida kasallikning oldini olishning markaziy yo’li sifatida reproduktiv davrgacha MMR preparati bilan emlatish, virus tashuvchisi bilan kontaktdan so’ng immunoglobulin orqali himoya choralarini ko’rish, shuningdek o’z vaqtida tashxis qo’yish va qo’llab-quvvatlash xarakteridagi terapiya asoslari batafsil yoritildi.
References
Jahon Sog’liqni Saqlash Tashkiloti (JSST). Qizamiq bo’yicha rasmiy ma’lumotlar va profilaktika tavsiyalari.
Centers for Disease Control and Prevention (CDC). Measles (Rubeola): Clinical Overview and Pregnancy Complications. Atlanta, GA: CDC.
American College of Obstetricians and Gynecologists (ACOG). Measles, Mumps, Rubella (MMR) Vaccination and Management of Obstetric–Gynecologic Patients During a Measles Outbreak. Practice Advisory, 2024.
Society for Maternal-Fetal Medicine (SMFM). Measles in Pregnancy: Clinical and Patient Resources.
Rasmussen S.A. et al. What Obstetric Health Care Providers Need to Know About Measles and Pregnancy. CDC, MMWR.
Ragusa R. va boshq. Measles and Pregnancy: Immunity and Immunization — What Can Be Learned from Observing Complications during an Epidemic Year. 2020.
Occupational Safety and Health Administration (OSHA). Measles — Control and Prevention.